ADVISORY, Feb. 27, 2007 (PRIME NEWSWIRE) --
What: Isaac Bentwich, M.D., Founder and Chief Architect of Rosetta Genomics, Ltd.(ROSG) will preside over the closing bell to celebrate the company's initial public offering on NASDAQ. Rosetta Genomics Ltd. listed on February 26, 2007. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Tuesday, February 27, 2007 at 4 p.m. ET Contacts: Tamir Kazaz 972.894.8.4759; tamir_ka@rosettagenomics.com NASDAQ MarketSite: Jolene Libretto; 646.441.5220; 347.219.9539 Jolene.Libretto@NASDAQ.com
Feed Information:
The closing bell is available from 3:50 p.m. to 4:05 p.m. on uplink IA-6 C-band/transponder 17. The downlink frequency is 4040 Vertical; Audio 6.2-6.8 The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.
Webcast:
A live Webcast of the NASDAQ Closing Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm
Photos:
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About Rosetta Genomics Ltd. (ROSG):
Rosetta Genomics is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs, which are believed to play an important role in regulating protein production. Rosetta has developed an early and strong intellectual property position related to the development and commercialization of microRNA-based products. Rosetta's current programs are focused on the development of microRNA-based diagnostic and therapeutic products for various cancers and infectious diseases.